1. Home
  2. IMMP vs EM Comparison

IMMP vs EM Comparison

Compare IMMP & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • EM
  • Stock Information
  • Founded
  • IMMP 1987
  • EM 2017
  • Country
  • IMMP Australia
  • EM China
  • Employees
  • IMMP N/A
  • EM N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • EM Other Consumer Services
  • Sector
  • IMMP Health Care
  • EM Consumer Discretionary
  • Exchange
  • IMMP Nasdaq
  • EM Nasdaq
  • Market Cap
  • IMMP 304.0M
  • EM 298.5M
  • IPO Year
  • IMMP N/A
  • EM 2021
  • Fundamental
  • Price
  • IMMP $1.78
  • EM $1.12
  • Analyst Decision
  • IMMP Buy
  • EM Strong Buy
  • Analyst Count
  • IMMP 2
  • EM 1
  • Target Price
  • IMMP $8.50
  • EM $1.00
  • AVG Volume (30 Days)
  • IMMP 82.5K
  • EM 331.1K
  • Earning Date
  • IMMP 03-25-2025
  • EM 03-06-2025
  • Dividend Yield
  • IMMP N/A
  • EM 2.36%
  • EPS Growth
  • IMMP N/A
  • EM N/A
  • EPS
  • IMMP N/A
  • EM 0.01
  • Revenue
  • IMMP $3,019,249.00
  • EM $261,961,935.00
  • Revenue This Year
  • IMMP N/A
  • EM N/A
  • Revenue Next Year
  • IMMP $20.28
  • EM $6.16
  • P/E Ratio
  • IMMP N/A
  • EM $74.86
  • Revenue Growth
  • IMMP 24.11
  • EM N/A
  • 52 Week Low
  • IMMP $1.65
  • EM $0.50
  • 52 Week High
  • IMMP $3.34
  • EM $1.18
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 41.69
  • EM 51.48
  • Support Level
  • IMMP $1.65
  • EM $1.11
  • Resistance Level
  • IMMP $1.88
  • EM $1.15
  • Average True Range (ATR)
  • IMMP 0.10
  • EM 0.03
  • MACD
  • IMMP -0.01
  • EM -0.01
  • Stochastic Oscillator
  • IMMP 41.94
  • EM 40.00

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.

Share on Social Networks: